Trademark: 97239487
Word
ABTAYVA
Status
Pending
Status Code
731
Status Date
Tuesday, December 19, 2023
Serial Number
97239487
Mark Type
4000
Filing Date
Wednesday, January 26, 2022
Published for Opposition
Tuesday, November 1, 2022

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events
Dec 21, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2023
Sou Extension 2 Granted
Dec 19, 2023
Sou Extension 2 Filed
Dec 19, 2023
Sou Teas Extension Received
Jun 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 15, 2023
Sou Extension 1 Granted
Jun 15, 2023
Sou Extension 1 Filed
Jun 15, 2023
Sou Teas Extension Received
Dec 27, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Published For Opposition
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Sep 26, 2022
Approved For Pub - Principal Register
Sep 20, 2022
Assigned To Examiner
Jan 31, 2022
New Application Office Supplied Data Entered
Jan 29, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24